Simon Voelkl
Overview
Explore the profile of Simon Voelkl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
1358
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salou S, Voelkl S, Keller B, Ehl S, Naumann-Bartsch N
J Clin Immunol
. 2023 Dec;
44(1):37.
PMID: 38159157
No abstract available.
2.
Handl S, von Heydebrand F, Voelkl S, Oostendorp R, Wilke J, Kremer A, et al.
Leuk Lymphoma
. 2021 May;
62(11):2679-2689.
PMID: 33999745
Molecular targets of tyrosine kinase inhibitors are not restricted to the B-cell compartment but also regulate functions in the tumor microenvironment. Increasing evidence suggests that B-cell receptor-associated kinases like protein...
3.
von Heydebrand F, Fuchs M, Kunz M, Voelkl S, Kremer A, Oostendorp R, et al.
Stem Cells
. 2021 Feb;
39(6):819-830.
PMID: 33539629
Survival of chronic lymphocytic leukemia (CLL) cells critically depends on the support of an adapted and therefore appropriate tumor microenvironment. Increasing evidence suggests that B-cell receptor-associated kinases such as protein...
4.
Menzner A, Rottmar T, Voelkl S, Bosch J, Mougiakakos D, Mackensen A, et al.
Cancers (Basel)
. 2021 Feb;
13(3).
PMID: 33530408
Background And Aims: Induction of myeloid-derived suppressor cells (MDSC) is a critical step in immune cell evasion by different cancer types, including liver cancer. In the liver, hepatic stromal cells...
5.
Ullrich E, Bosch J, Aigner M, Voelkl S, Kroeger I, Hoffmann P, et al.
Cancer Immunol Immunother
. 2011 Dec;
61(3):433-43.
PMID: 22200930
No abstract available.
6.
Gary R, Voelkl S, Palmisano R, Ullrich E, Bosch J, Mackensen A
J Immunol
. 2011 Dec;
188(2):744-52.
PMID: 22174448
Upon specific interaction with APCs, T cells capture membrane fragments and surface molecules in a process termed trogocytosis. In this study, we demonstrate that human Ag-specific CD8(+) T cells acquire...
7.
Characterization of the immunoregulatory function of human TCR-αβ+ CD4- CD8- double-negative T cells
Voelkl S, Gary R, Mackensen A
Eur J Immunol
. 2011 Feb;
41(3):739-48.
PMID: 21287552
Regulatory T cells (Tregs) play an important role in the maintenance of immune tolerance to self-antigens and are involved in modulating immune responses in autoimmunity, transplant rejection, and tumor immunity....
8.
Voelkl S, Moore T, Rehli M, Nishimura M, Mackensen A, Fischer K
Cancer Immunol Immunother
. 2008 Oct;
58(5):709-18.
PMID: 18836718
The immune attack against malignant tumors require the concerted action of CD8+ cytotoxic T lymphocytes (CTL) as well as CD4+ T helper cells. The contribution of T cell receptor (TCR)...
9.
Moore T, Lyons G, Brasic N, Roszkowski J, Voelkl S, Mackensen A, et al.
Cancer Immunol Immunother
. 2008 Oct;
58(5):719-28.
PMID: 18836717
Effective immunotherapy using T cell receptor (TCR) gene-modified T cells requires an understanding of the relationship between TCR affinity and functional avidity of T cells. In this study, we evaluate...
10.
Fischer K, Hoffmann P, Voelkl S, Meidenbauer N, Ammer J, Edinger M, et al.
Blood
. 2007 Jan;
109(9):3812-9.
PMID: 17255361
A characteristic feature of tumors is high production of lactic acid due to enhanced glycolysis. Here, we show a positive correlation between lactate serum levels and tumor burden in cancer...